MODERATOR
:
SPEAKER
(S):
Dr. Laura Cooling, MD, MS, Associate Professor, University of Michigan
Fatal Hyperhemolysis in a Sickle Cell Patient
Alice Chen, MD, PhD, Medical Director, Molecular Pathology Section; Associate Medical Director, Blood Donor Program, St. Luke's Episocopal Hospital
Fatal Hemolysis Due to an anti-Pr
David Yawn, MD, Professor of Pathology, Baylor College of Mdeicine
Acute Hemolysis Due to Antibody with Broad Thermal Range
Description
This session will describe three cases of acute hemolytic anemia, the laboratory results, clinical conditions, and the methods used for therapy. Hyperhemolysis, with or without the presence of underlying red cell antibodies, is frequently overlooked or misinterpreted by the attending staff. While pernicious autoimmune hemolytic anemia is frequently associated with Rh specificities, acute and frequently fatal autoimmune hemolytic anemia is associated with glycophorin receptors (MNS and Ge blood group and Pr receptors). Early recognition of a serological specificity may suggest the most appropriate therapeutic methods. The high mortality rate of these and similar cases will be discussed.
-
Compare and contrast blood group antibodies associated with cases of acute and frequently fatal hemolytic anemia.
-
Describe the distinguishing characteristics of a patient undergoing hyperhemolysis.
-
Discuss the potential interactive impact of transfusions, medications, and apheresis therapy for hyperhemolysis.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.